CRL POLYMORPHISMS AND SESCEPTIBILITY TO SEVERE MALARIA
CRL 多态性和对严重疟疾的敏感性
基本信息
- 批准号:2673158
- 负责人:
- 金额:$ 26.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-09-30 至 2001-08-31
- 项目状态:已结题
- 来源:
- 关键词:African Plasmodium falciparum antigen antibody reaction blood group antigens cellular immunity complement receptor disease /disorder proneness /risk erythrocytes gene mutation genetic polymorphism health surveys host organism interaction human subject immune adherence reaction malaria molecular cloning molecular pathology monoclonal antibody nucleic acid sequence pathologic process polymerase chain reaction receptor expression serology /serodiagnosis tissue /cell culture virulence western blottings
项目摘要
Of the four species of Plasmodium, P. falciparum causes the greatest
morbidity and highest mortality and remains a major world health
problem. It has been suggested that severity of disease may relate to
the ability of infected erythrocytes to sequester in the venules of
various organs. Sequestration appears to be dependent upon knobs
produced on the surface of infected erythrocytes which mediate
attachment to the endothelium. Knob positive erythrocytes can also form
rosettes with uninfected cells; rosetting being one of the few known
virulence factors related to severe malaria. However, specific ligand-
receptor interactions involved in this mechanism are not well
understood. Recently, a P. falciparum var gene product has been
identified as the ligand (Duffy binding like domain or DBL-1) and
complement receptor one (CR1) its putative receptor in in vitro rosette
formation. CR1 exhibits genetic polymorphism in 3 ways: molecular
weight, the Knops blood group and expression level differences on
erythrocytes. The low expression of CR1 and one of the Knops blood
group phenotypes, Sl(a-), reduces the ability to form rosettes. The
Sl(a-) phenotype is detected at high frequency in African-derived
populations but is rare in populations from non-malarious regions. This
raises the possibility that CR1 polymorphism confers a selective
advantage by reducing the potential for rosette formation between P.
falciparum-infected and uninfected erythrocytes. Therefore, this
proposal will study how the genetic polymorphisms of CR1 relate to
rosette formation and the pathophysiology of severe P.falciparum
malaria. To accomplish this we will identify the molecular basis of the
CR1 polymorphisms found more frequently in African-derived population
using RT-PCR, heteroduplex screening, DNA cloning and DNA sequence
analysis from antigen positive and negative donors. Employing this
information, their genetic relevance will be tested by screening large
malaria DNA databases by PCR-based techniques. Functional relevance of
these polymorphisms will be examined by utilizing CR1 deletion
constructs to identify the regions of host-parasite interaction and
blocking these interactions with monoclonal antibodies to CR1 and/or
recombinant soluble CR1. Therefore, this research should be viewed as
a first step in the development of new chemotherapeutic agents that
prevent pathology associated with severe malaria.
在四种疟原虫中,恶性疟原虫引起的疟疾发病率最高,
发病率和死亡率最高,仍然是世界卫生组织的一个主要问题。
问题.有人认为,疾病的严重程度可能与
感染的红细胞在微静脉中隔离的能力
各种器官。隔离似乎取决于旋钮
在受感染的红细胞表面产生,
附着于内皮。Knob阳性红细胞也可形成
用未感染的细胞进行玫瑰花结;玫瑰花结是少数已知的
与严重疟疾有关的毒力因子。但是,特定的配体-
参与该机制的受体相互作用不佳
明白最近,恶性疟原虫变种基因产物已被
鉴定为配体(Duffy结合样结构域或DBL-1),
补体受体1(CR 1)及其体外玫瑰花结中的假定受体
阵CR 1在3个方面表现出遗传多态性:分子
体重,Knops血型和表达水平差异
红细胞CR 1的低表达和Knops血液中的一种
组表型Sl(a-)降低了形成玫瑰花结的能力。的
Sl(a-)表型在非洲来源的
但在非疟疾流行地区的人群中很少见。这
提出了CR 1多态性赋予选择性
通过降低P.
感染和未感染的红细胞。因此本
这项提案将研究CR 1的遗传多态性如何与
花结形成与重症恶性疟原虫的病理生理
疟疾为了做到这一点,我们将确定的分子基础,
CR 1多态性在非洲人群中更常见
利用RT-PCR、异源双链筛选、DNA克隆和DNA序列测定
来自抗原阳性和阴性供体的分析。采用这种
信息,它们的遗传相关性将通过筛选大型
疟疾DNA数据库的PCR为基础的技术。功能相关性
这些多态性将通过使用CR 1缺失来检查
构建体以鉴定宿主-寄生虫相互作用的区域,
阻断这些与CR 1单克隆抗体的相互作用,和/或
重组可溶性CR 1。因此,这项研究应被视为
这是开发新化疗剂的第一步,
预防与严重疟疾相关的病理学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOANN M MOULDS其他文献
JOANN M MOULDS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOANN M MOULDS', 18)}}的其他基金
CR1 Polymorphisms and Susceptibility to Severe Malaria
CR1 多态性与严重疟疾的易感性
- 批准号:
6545283 - 财政年份:2002
- 资助金额:
$ 26.18万 - 项目类别:
CRL POLYMORPHISMS AND SUSCEPTIBILITY TO SEVERE MALARIA
CRL 多态性和严重疟疾的易感性
- 批准号:
6096253 - 财政年份:1997
- 资助金额:
$ 26.18万 - 项目类别:
CRL POLYMORPHISMS AND SESCEPTIBILITY TO SEVERE MALARIA
CRL 多态性和对严重疟疾的敏感性
- 批准号:
2462899 - 财政年份:1997
- 资助金额:
$ 26.18万 - 项目类别:
CRL POLYMORPHISMS AND SESCEPTIBILITY TO SEVERE MALARIA
CRL 多态性和对严重疟疾的敏感性
- 批准号:
6171125 - 财政年份:1997
- 资助金额:
$ 26.18万 - 项目类别:
CRL POLYMORPHISMS AND SESCEPTIBILITY TO SEVERE MALARIA
CRL 多态性和对严重疟疾的敏感性
- 批准号:
6294370 - 财政年份:1997
- 资助金额:
$ 26.18万 - 项目类别:
CRL POLYMORPHISMS AND SESCEPTIBILITY TO SEVERE MALARIA
CRL 多态性和对严重疟疾的敏感性
- 批准号:
2887658 - 财政年份:1997
- 资助金额:
$ 26.18万 - 项目类别:
相似海外基金
Genomics and sero-epidemiology of Plasmodium falciparum malaria in a pre-elimination setting
消灭前环境中恶性疟原虫疟疾的基因组学和血清流行病学
- 批准号:
10666280 - 财政年份:2023
- 资助金额:
$ 26.18万 - 项目类别:
Elucidating mechanisms for artemisinin-induced dormancy in Plasmodium falciparum
阐明青蒿素诱导恶性疟原虫休眠的机制
- 批准号:
10742385 - 财政年份:2023
- 资助金额:
$ 26.18万 - 项目类别:
Investigating the role of SCF ubiquitin ligases during sexual development of Plasmodium falciparum
研究 SCF 泛素连接酶在恶性疟原虫性发育过程中的作用
- 批准号:
MR/W025566/1 - 财政年份:2023
- 资助金额:
$ 26.18万 - 项目类别:
Research Grant
Rotation 1: Investigating the role(s) of the putative FANCJ helicase in the malaria parasite Plasmodium falciparum
第 1 轮:研究假定的 FANCJ 解旋酶在疟原虫恶性疟原虫中的作用
- 批准号:
2886902 - 财政年份:2023
- 资助金额:
$ 26.18万 - 项目类别:
Studentship
Exploring the role of phosphoinositides in the trafficking of proteins to the apical complex in the malaria parasite Plasmodium falciparum.
探索磷酸肌醇在疟原虫恶性疟原虫顶复合体蛋白质运输中的作用。
- 批准号:
495093 - 财政年份:2023
- 资助金额:
$ 26.18万 - 项目类别:
Operating Grants
DDT-BMQ-0000100 Qualification of the Plasmodium falciparum 18S rRNA biomarker for malaria-endemic controlled human malaria infection studies
DDT-BMQ-0000100 疟疾流行控制人类疟疾感染研究中恶性疟原虫 18S rRNA 生物标志物的鉴定
- 批准号:
10836140 - 财政年份:2023
- 资助金额:
$ 26.18万 - 项目类别:
Defining molecular determinants of Plasmodium falciparum hematopoietic infection using single cell profiling and genetics
使用单细胞分析和遗传学定义恶性疟原虫造血系统感染的分子决定因素
- 批准号:
EP/Y003705/1 - 财政年份:2023
- 资助金额:
$ 26.18万 - 项目类别:
Fellowship
Detailed mechanism of trafficking proteins involved in the virulence of Plasmodium falciparum
恶性疟原虫毒力中涉及的运输蛋白的详细机制
- 批准号:
22KF0032 - 财政年份:2023
- 资助金额:
$ 26.18万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Étude du rôle de la phosphatase de phosphoinositides SAC1 dans le trafic de protéines au complexe apical chez le parasite de la malaria Plasmodium falciparum
疟疾疟原虫顶端寄生虫复合物中磷酸肌醇磷酸酶 SAC1 的研究
- 批准号:
486094 - 财政年份:2022
- 资助金额:
$ 26.18万 - 项目类别:
Studentship Programs
In vitro bioreactor production of a genetically modified late liver stage-arresting replication competent Plasmodium falciparum sporozoite vaccine
体外生物反应器生产具有复制能力的转基因晚期肝阶段恶性疟原虫子孢子疫苗
- 批准号:
10547414 - 财政年份:2022
- 资助金额:
$ 26.18万 - 项目类别: